Effect of Tepotinib on the PK of the P-gp Substrate Dabigatran Etexilate
Clinical trial NCT03492437 · COMPLETED
Trial details
- NCT number
- NCT03492437
- Sponsor
- Merck KGaA, Darmstadt, Germany
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-17
- Primary completion
- 2018-08-27
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.